Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT

Background: The treatment of people with diabetes with metformin can reduce cardiovascular disease (CVD) and may reduce the risk of cancer. However, it is unknown whether or not metformin can reduce the risk of these outcomes in people with elevated blood glucose levels below the threshold for diabe...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Simon J Griffin, M Angelyn Bethel, Rury R Holman, Kamlesh Khunti, Nicholas Wareham, Gwen Brierley, Melanie Davies, Andrew Dymond, Rose Eichenberger, Philip Evans, Alastair Gray, Colin Greaves, Kyla Harrington, Graham Hitman, Greg Irving, Sarah Lessels, Ann Millward, John R Petrie, Martin Rutter, Mike Sampson, Naveed Sattar, Stephen Sharp
格式: Artigo
語言:Inglês
出版: NIHR Journals Library 2018-04-01
叢編:Health Technology Assessment
主題:
prevention
cardiovascular risk
cardiovascular disease
metformin
diabetes
type 2 diabetes
impaired glucose tolerance
hyperglycaemia
在線閱讀:https://doi.org/10.3310/hta22180
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍